ArticleThe Journal of experimental medicine2019
Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses.
Xiaodong Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
64 papers cite itlatest 60 shown
this papercites it